TheProfitWatch

PODD - Insulet Corporation

Day 1m 10m 60m PreMarket Market AfterHours Gap
314.14 16.38 (5.21%) -0.16 (-0.05%) -0.47 (-0.14%) -2.88 (-0.87%) 0.86 (0.27%) 8.56 (2.66%) -0.7 (-0.22%) 3.3 (1.06%)

Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.

Category: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Market Period: Market

Earnings & Ratios

Basic EPS:
0.32
Diluted EPS:
0.32
Basic P/E:
1032.875
Diluted P/E:
1032.875
RSI(14) 1m:
63.61
VWAP:
330.48
RVol:

Events

Period Kind Movement Occurred At

Related News